Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd. is a prominent biopharmaceutical company based in China, engaged in the research, development, and commercialization of innovative therapeutics for a range of diseases. The company's primary focus lies in the discovery and production of novel antibodies and biologics aimed at treating cancer, autoimmune, metabolic, and infectious diseases. As a key player in China's rapidly advancing biotech industry, Shanghai Junshi Biosciences is known for leveraging cutting-edge technologies such as monoclonal antibodies and bispecific antibodies in its product development pipeline. Through strategic collaborations and partnerships with global pharmaceutical firms, the company enhances its R&D capabilities and extends its reach beyond domestic borders. With a commitment to addressing unmet medical needs, Shanghai Junshi Biosciences plays a vital role in the healthcare and life sciences sectors, offering potential groundbreaking treatments and contributing significantly to the global biotech landscape.